Atlas Drills Another Large Step-Out at Great Atlantic
10 juin 2022 10h16 HE
|
Atlas Salt Inc.
ST. JOHN’S, Newfoundland and Labrador, June 10, 2022 (GLOBE NEWSWIRE) -- Atlas Salt (the “Company” or “Atlas” - TSXV: SALT) is pleased to report that as the Company progresses toward completion of...
Biofrontera reports preliminary unaudited sales revenue for the third quarter of 2020
09 oct. 2020 10h32 HE
|
Biofrontera AG
Leverkusen, Germany, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports...
Biofrontera AG plans mediation to resolve (legal) disputes
11 sept. 2020 07h33 HE
|
Biofrontera AG
Leverkusen, Germany, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-Group”), an international biopharmaceutical...
European Medicines Agency recommends indication expansion of Ameluz® for treatment of actinic keratoses on the extremities and trunk/neck
03 févr. 2020 05h45 HE
|
Biofrontera AG
Leverkusen, Germany, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that...
Biofrontera strengthens commercial focus with reorganization of its US business
06 janv. 2020 09h00 HE
|
Biofrontera AG
Leverkusen, Germany, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced a new...
Extraordinary General Meeting of Biofrontera AG: Biofrontera Management Board supported by large majority
20 déc. 2019 09h35 HE
|
Biofrontera AG
Leverkusen, Germany, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced the...
Biofrontera Reports Third Quarter 2019 Financial Results and Revises Guidance
19 nov. 2019 03h25 HE
|
Biofrontera AG
Leverkusen, Germany, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its...
Draganfly Inc. Announces Frankfurt Listing
15 nov. 2019 09h15 HE
|
Draganfly Inc
Vancouver, British Columbia, Nov. 15, 2019 (GLOBE NEWSWIRE) -- Draganfly Inc. (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading systems developer within the...
Isracann Biosciences Announces OTC Trading Symbol Change to “ISCNF”, Effective November 15, 2019
15 nov. 2019 09h00 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Nov. 15, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (FRA: A2PT0E) (formerly OTC: ATLED) (OTC: ISCNF) (the “Company”) an Israel-based company focused...
Annual General Meeting of Biofrontera AG: Biofrontera Management Board approved by large majority
11 juil. 2019 05h23 HE
|
Biofrontera AG
Leverkusen, Germany, July 11, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced the...